Published in J Leukoc Biol on September 01, 1994
Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J Virol (2001) 2.16
Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev (1997) 1.74
Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev (2004) 1.48
The dimer initiation sequence stem-loop of human immunodeficiency virus type 1 is dispensable for viral replication in peripheral blood mononuclear cells. J Virol (2003) 1.37
Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection. Infect Immun (2002) 1.32
Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability. J Virol (2002) 1.14
Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections. J Virol (2007) 1.07
Group V secretory phospholipase A2 modulates phagosome maturation and regulates the innate immune response against Candida albicans. J Immunol (2009) 1.03
Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines. Proc Natl Acad Sci U S A (1998) 1.03
Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1. J Virol (2004) 1.02
Phagocytic activity in human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol (2005) 1.01
Immune reconstitution disease associated with parasitic infections following antiretroviral treatment. Parasite Immunol (2006) 1.01
The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages. J Virol (2012) 0.97
Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy. Clin Exp Immunol (2012) 0.81
Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120. J Clin Invest (1997) 0.79
Gamma/Delta T cell mRNA levels decrease at mucosal sites and increase at lymphoid sites following an oral SIV infection of macaques. Curr HIV Res (2008) 0.79
Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene. Infect Immun (2009) 0.77
Human cytomegalovirus and Epstein-Barr virus inhibit oral bacteria-induced macrophage activation and phagocytosis. Oral Microbiol Immunol (2009) 0.76
Nonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCG. PLoS One (2016) 0.75
Candida albicans delays HIV-1 replication in macrophages. PLoS One (2013) 0.75
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58
Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1984) 4.64
An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer (1978) 3.82
The natural history of Hendra and Nipah viruses. Microbes Infect (2001) 3.77
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med (1988) 3.49
Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol (1971) 3.33
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med (1999) 3.30
Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet (1985) 2.88
Prospective study of chlamydial infection in neonates. Lancet (1979) 2.80
Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol (1996) 2.75
Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56
Unique monocyte subset in patients with AIDS dementia. Lancet (1997) 2.55
Development of allergy in children. I. Association with virus infections. J Allergy Clin Immunol (1979) 2.48
Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study. Epidemiology (1995) 2.41
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med (1986) 2.36
Influence of immunological factors in respiratory syncytial virus disease. Arch Environ Health (1970) 2.30
Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens. J Clin Microbiol (1983) 2.27
Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis (1987) 2.19
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax (2013) 2.17
Interferon therapy for condylomata acuminata. N Engl J Med (1986) 2.16
Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 2.14
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
AKR leukemogenesis: identification and biological significance of thymic lymphoma receptors for AKR retroviruses. Cell (1979) 2.10
NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop. Am Rev Respir Dis (1987) 2.09
Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res (1975) 2.02
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Mild cognitive impairment in prediagnosed Huntington disease. Neurology (2010) 1.96
Review of University of British Columbia Family Practice Resident Research Projects 1990-1997. Fam Med (1999) 1.94
Isolation of molecules recognized by monoclonal antibodies and antisera: the solid phase immunoisolation technique. Anal Biochem (1984) 1.91
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1991) 1.89
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med (1990) 1.89
Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocyte/macrophages. AIDS Res Hum Retroviruses (1987) 1.86
Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol (1999) 1.80
Active site mutagenesis of the AIDS virus protease and its alleviation by trans complementation. EMBO J (1988) 1.80
Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med (1969) 1.79
Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. J Infect Dis (1971) 1.78
Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun (1987) 1.77
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol (1990) 1.72
Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis (1990) 1.71
Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J Clin Invest (1991) 1.71
Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus. Rev Infect Dis (1985) 1.66
Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection. Am Rev Respir Dis (1991) 1.64
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
Murine leukaemogenesis: monoclonal antibodies to T-cell determinants arrest T-lymphoma cell proliferation. Nature (1980) 1.56
Experimental asbestosis with four types of fibers: importance of small particles. Ann N Y Acad Sci (1965) 1.55
Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis (1990) 1.55
Use of laparoscopy to determine the microbiologic etiology of acute salpingitis. Am J Obstet Gynecol (1979) 1.52
Influenza in patients with human immunodeficiency virus infection. Chest (1990) 1.50
Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1994) 1.50
Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS. J Clin Microbiol (1992) 1.49
Nine episodes of infective endocarditis in one patient--a new record. West J Med (1987) 1.48
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med (1989) 1.48
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Exopolysaccharide production by viridans streptococci in experimental endocarditis. Infect Immun (1984) 1.45
Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother (1989) 1.41
Intraoperative high dose rate brachytherapy in recurrent or metastatic colorectal carcinoma. Ann Surg Oncol (1998) 1.39
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol (2004) 1.39
Hypomagnesaemia in a calf. Vet Rec (1992) 1.38
Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse. Ann Intern Med (1976) 1.37
Evaluation of influenza virus mutants for possible use in a live virus vaccine. Bull World Health Organ (1969) 1.37
Evaluation of an interferon inducer in viral respiratory disease. JAMA (1972) 1.37
Suppression of human immunodeficiency virus type 1 activity in vitro by oligonucleotides which form intramolecular tetrads. J Biol Chem (1995) 1.36
Diagnostic X-ray and ultrasound exposure and risk of childhood cancer. Br J Cancer (1994) 1.36
Hantavirus reservoir hosts associated with peridomestic habitats in Argentina. Emerg Infect Dis (2000) 1.36
Surface CD4 is critical to in vitro HIV infection of human alveolar macrophages. AIDS Res Hum Retroviruses (1996) 1.35
Enzymatic modification of glycocalyx in the treatment of experimental endocarditis due to viridans streptococci. J Infect Dis (1987) 1.33
Prolonged use of methyldopa in severe hypertension in pregnancy. Br Med J (1966) 1.31
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31
A method of removing starch powder from surgeons' gloves. Ann R Coll Surg Engl (1975) 1.30
Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS. J Infect Dis (1988) 1.30
In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria. Antimicrob Agents Chemother (1981) 1.29
Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev (2003) 1.28
Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo. J Clin Invest (1988) 1.26
Incidence of acute mountain sickness at intermediate altitude. JAMA (1989) 1.25
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Arch Dis Child (1994) 1.25
Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol (2002) 1.24
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer (1981) 1.23
Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation (1989) 1.23
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med (1987) 1.22
Cultured stem-cells from human testicular teratomas: the nature of human embryonal carcinoma, and its comparison with two types of yolk-sac carcinoma. Int J Cancer (1987) 1.22
Effectiveness of nurse triage in the emergency department of an urban county hospital. JACEP (1976) 1.22
Topoisomerase I phosphorylation in vitro and in rapidly growing Novikoff hepatoma cells. EMBO J (1985) 1.21
HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS (1998) 1.21
Temperature-sensitive mutants of influenza virus. VI. Transfer of TS lesions from the Asian subtype of influenza A virus (H2N2) to the Hong Kong subtype (H3N2). Virology (1975) 1.20
HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression. J Acquir Immune Defic Syndr (2003) 1.20
The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.20
An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol (2001) 1.19
Client-centred practice: what does it mean and does it make a difference? Can J Occup Ther (1995) 1.19
Experimental asbestosis in the guinea-pig. J Pathol Bacteriol (1966) 1.19
The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation. Contemp Top Immunobiol (1980) 1.19